Showing 4911-4920 of 21485 results for "".
- U.S. Allergists Shifted Toward Multispecialty Groupshttps://reachmd.com/news/us-allergists-shifted-toward-multispecialty-groups/2488349/Key Takeaways Across U.S. allergy/immunology practice settings, the allergist workforce rose 10% from 2015 to 2023 while the number of practices with allergists fell 11%. Employment shifted toward multispecialty groups over the study period, while solo and allergist-
- Upneeq Launches Super-sized Marketing Campaignhttps://reachmd.com/news/upneeq-launches-super-sized-marketing-campaign-for-ny-fashion-week/2488350/Upneeq® (oxymetazoline hydrochloride ophthalmic solution), 0.1%, is bringing an oversized brand activation to New York Fashion Week, translating its signature single-use packet into a larger-than-life installation dubbed “The Big Peach Packet,” according to a press announcement from the manufactu
- BostonGene to Present New Genomic Tools for Blood Cancer Treatment Selection at SOHO 2026https://reachmd.com/news/bostongene-to-present-new-genomic-tools-for-blood-cancer-treatment-selection-at-soho-2026/2488343/Key Takeaways BostonGene will present two new poster studies at the SOHO 2026 Annual Meeting, September 9–12 in Houston, Texas. One introduces an "Actionability Score" to guide immunotherapy target selection in multiple myeloma; the other validates a genetic
- Disc Medicine to Present New Data on Two Rare Blood Disease Therapies at SOHO 2026https://reachmd.com/news/disc-medicine-to-present-new-data-on-two-rare-blood-disease-therapies-at-soho-2026/2488344/Key Takeaways Disc Medicine (NASDAQ: IRON) will present clinical data across its hematology portfolio at the SOHO 2026 Annual Meeting, September 9–12 in Houston, Texas. Highlights include an oral presentation of initial Phase 2 data from
- DRESS: Tofacitinib Shows Glucocorticoid-Sparing Potentialhttps://reachmd.com/news/dress-tofacitinib-shows-glucocorticoid-sparing-potential/2488346/Adding tofacitinib to systemic glucocorticoid therapy was associated with reduced glucocorticoid exposure and faster clinical improvement among patients with drug reaction with eosinophilia and systemic symptoms (DRESS), according to a study published online in the
- Robotic Gastrectomy Lowers Blood Loss, Conversions in Japanhttps://reachmd.com/news/robotic-gastrectomy-lowers-blood-loss-conversions-in-japan/2488323/Key Takeaways In Japan, patients undergoing minimally invasive distal or total gastrectomy for gastric cancer had shorter postoperative hospital stays and fewer conversions to open surgery with robotic surgery than with laparoscopy. Robotic distal and total gastrecto
- Omalizumab Outperformed MOIT in Multifood Allergy Trialhttps://reachmd.com/news/omalizumab-outperformed-moit-in-multifood-allergy-trial/2488316/Key Takeaways Patients with peanut allergy plus at least two additional food allergies in OUTMATCH stage 2 had higher overall treatment success with continued omalizumab than with omalizumab-facilitated multiallergen oral immunotherapy. Completion was more common wit
- Supported Running Study Finds Faster Repeat Neural Adaptationhttps://reachmd.com/news/supported-running-study-finds-faster-repeat-neural-adaptation/2488304/Key Takeaways Lower-body positive pressure treadmill running in healthy young men left some neural adjustments incomplete at the end of the first unweighting transition. Several unweighting adjustments were completed sooner during the second exposure, a pattern the a
- CKD Stage Predicts Outcomes After Left Main PCIhttps://reachmd.com/news/ckd-stage-predicts-outcomes-after-left-main-pci/2488315/Key Takeaways In patients undergoing intracoronary imaging-guided percutaneous coronary intervention for de novo left main disease in a Japanese multicenter registry, 3-year major adverse cardiovascular and cerebrovascular event rates increased with worsening chronic kidney d
- Fruit, Vegetables and NMIBC Recurrence Riskhttps://reachmd.com/news/fruit-vegetables-and-nmibc-recurrence-risk/2488311/Key Takeaways In a Dutch prospective NMIBC cohort of more than 1,000 patients, higher fruit and vegetable intake 3 months after diagnosis was associated with lower first recurrence risk. Increases in total fruit and vegetable intake from before diagnosis to 3 months